Most Read News

The Exchange had sought clarification from Jagsonpal Pharmaceuticals Limited with respect to announcement dated 16-07-2022 regarding Appointment of Statutory Auditor.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:Change in directors, key managerial personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer:1. Brief profile (in case of appointment)The response of the company is attached.

Karma Energy Limited has informed the Exchange about press release dated 13-Aug-2022 titled Extract of Financial Results for the quarter ended 30th June, 2022

Hindustan Construction Company Limited has informed the Exchange about Assignment of Credit Rating

Sarthak Metals Limited has informed the Exchange about press release dated 16-Aug-2022 titled Press and Media release

Aegis Logistics Limited has informed the Exchange about Investor Presentation

The Exchange had sought clarification from Gammon India Limited with respect to announcement dated 10-08-2022 regarding Outcome of Board Meeting.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:Change in directors, key managerial personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer:1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authorityThe response of the company is attached.

Piramal Enterprises Limited has informed the Exchange about Certified copy of order passed by by Hon???ble National Company Law Tribunal, Mumbai Bench sanctioning the Scheme.

Unichem Laboratories Limited has informed the Exchange about press release dated 16-Aug-2022 titled ANDA approval from United States Food and Drug Administration (USFDA) for Unichem???s Quetiapine Extended-Release Tablets USP.

Precot Limited has informed the Exchange about Investors Presentation for the quarter ended 30th June, 2022.

With respect to above we wish to inform you that Lyka Exports Limited a subsidiary, is amalgamating with its holding Company w.e.f. 1st April, 2022 (Appointed Date). We provide following documents for your processing our application for amalgamation viz:1.Scheme of Amalgamation.2.Board Resolutions passed by Board of Directors of Lyka Exports Limited and Lyka Labs Limited approving scheme of amalgamation of Lyka Exports Limited with Lyka Labs Limited. 3.Valuation Report provided by Bhavesh M. Rathod- Registered Valuer.4.Fairness Opinion regarding Valuation of Shares and Exchange Ratio provided by Kunvarji Finstock Private Limited- SEBI Registered Category I Merchant Banker. 5.Audit Committee Report.6.Auditors Certificate under section 133 of the Companies Act, 2013 provided by M/s. D. Kothary & Co, Chartered Accountants, for accounting treatment to be given in the proposed amalgamation separately for Lyka Labs Limited and Lyka Exports Limited.Limited has informed the Exchange abou